Luminex Corporation Places 5,000th Instrument
News Feb 21, 2008
Luminex Corporation has announced that it has recently delivered its 5,000th instrument to Beaumont Hospital in Royal Oak, Michigan. Beaumont Hospital, Royal Oak, will use the Luminex® 200™ instrument to perform the FDA-cleared Luminex xTAG™ Respiratory Viral Panel (RVP) to assist doctors in diagnosing respiratory infections.
"Multiplexing is, in many ways, the future of molecular diagnostics," said Dr. Domnita Crisan, medical director of the molecular pathology laboratory at Beaumont Hospital, Royal Oak. "The ability to run many tests at once provides us faster, more clinically relevant results. The Luminex instrument is an important multiplexing tool for us. It provides accurate results very quickly and efficiently, and is easy to use."
"Delivering our 5,000th instrument is an important milestone for Luminex as our proprietary xMAP® Technology, driven by the test menu expansion of our partners and the Luminex Assay Group, continues to gain momentum in the marketplace," said Patrick J. Balthrop, president and chief executive officer of Luminex Corporation.
Revolutionary Imaging Technique Uses CRISPR to Map DNA MutationsNews
The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.READ MORE
AIDS Vaccine Design: New Data Offers Important InsightNews
New data published in Immunity further illuminate how some human beings generate powerful, HIV-blocking antibodies. The results offer important insight into a potential AIDS vaccine design.READ MORE